Tech Mahindra Recognized in Three Categories at the 2025 Pharmaceutical Technology Excellence Awards by GlobalData

Tech Mahindra (NSE: TECHM), a leading global provider of technology consulting and digital solutions to enterprises across industries, announced that it has been recognized in three categories at the 2025 Pharmaceutical Technology Excellence Awards, powered by GlobalData. Tech Mahindra was named category winner for its capabilities across Safety, Research and Development, and Innovation, underscoring its position as a trusted digital transformation partner for pharmaceutical and medical device organizations worldwide.

Tech Mahindra received the Safety award for its AI-Enabled Pharmacovigilance solution, which reimagines drug safety as a continuous, data-driven function, improving case processing efficiency and signal detection. In Research and Development, the company was recognized in the Computer Software Assurance (CSA) and Computer System Validation (CSV) automation category for its AI-driven validation workflows that streamline compliance while adhering to GxP and regulatory requirements. The Innovation award was conferred for Tech Mahindra’s advanced end-to-end labeling automation through its GLAMS Impact Analysis solution, which integrates regulatory information management and artwork systems using NLP-driven algorithms.

Kunal Purohit, President, Next-Gen Services, Tech Mahindra, said, “Being recognized across three critical categories is a strong validation of our commitment to transforming the life sciences industry through purpose-built, AI-led solutions. By modernizing drug safety, clinical, and regulatory workflows, we are enabling faster, more informed decision-making while strengthening compliance and patient safety. This recognition reinforces our focus on delivering innovation that creates meaningful, real-world impact.”

The Pharmaceutical Technology Excellence Awards are among the most prestigious independent industry recognitions, celebrating organizations that demonstrate outstanding technological innovation and measurable impact across the life sciences value chain.

Ivetta Taylor, Business Development Manager, Global Data, said “This year, our judging panel has reviewed many point solutions but placed strong emphasis on integrated capabilities that deliver measurable impact across the life sciences value chain. Tech Mahindra stood out because its use of AI in pharmacovigilance, CSA/CSV, and labeling automation is already translating into faster safety case handling, more agile validation, and tighter control of labeling changes—going beyond efficiency to strengthen regulatory control, reduce risk, and improve patient outcomes.”

The recognition further strengthens Tech Mahindra’s commitment to advancing integrated, technology-driven solutions across safety, research, and innovation, helping life sciences organizations operate with greater agility, compliance, and confidence in an increasingly complex regulatory environment.